An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial (Preprint)
Authors:
- Michael S BusinelleMichael S Businelle
- Lorra GareyLGLorra Garey
- Matthew W GallagherMGMatthew W Gallagher
- Emily T HébertEHEmily T Hébert
- Anka VujanovicAVAnka Vujanovic
- Adam AlexanderAAAdam Alexander
- Krista KezbersKKKrista Kezbers
- Cameron MatoskaCMCameron Matoska
- Jillian RobisonJRJillian Robison
- Audrey MontgomeryAMAudrey Montgomery
- Michael J ZvolenskyMZMichael J Zvolensky
Preprint
- 20 April 2022
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Black smokers have greater difficulty in quitting and higher rates of smoking-related diseases and disabilities than the general population. The smoking disparities experienced by this group are, in part, a consequence of multiple chronic life stressors (eg, racial discrimination) that engender increased exposure to interoceptive stress symptoms (eg, anxiety), which can ultimately lead to smoking as a means of immediate emotion regulation. OBJECTIVE This study aimed to culturally adapt and initially test a novel mobile intervention (ie, Mobile Anxiety Sensitivity Program for Smoking [MASP]) that targets anxiety sensitivity (AS; a proxy for difficulty and responsivity to interoceptive stress) among Black smokers. The MASP intervention is culturally informed to address interoceptive stress management difficulties among Black smokers and is thus hypothesized to facilitate smoking cessation. METHODS In phase 1, a total of 25 Black smokers with elevated AS will be administered MASP for 6 weeks. Following the completion of phase 1, we will further refine the MASP based on qualitative and quantitative data from participants to produce the final MASP iteration. In phase 2, a total of 200 Black smokers with elevated AS will be enrolled and randomly assigned to receive nicotine replacement therapy and either the smartphone-based National Cancer Institute QuitGuide app for standard mobile smoking cessation treatment or the MASP intervention. All participants in phases 1 and 2 will be enrolled remotely and will complete a web-based study screener; smartphone-based baseline assessment; daily smartphone-based ecological momentary assessments for 6 weeks; phone-based end-of-treatment qualitative interviews; and smartphone-based follow-up assessments at postbaseline weeks 1, 2 (quit date), 3, 4, 5, 6, 28, and 54 (weeks 28 and 54 follow-ups will be completed by phase 2 participants only). The MASP intervention is intended to offset barriers to treatment and encourage treatment engagement via smartphones. RESULTS This project was funded in September 2020. Phase 1 data collection began in January 2022. Phase 2 data collection is scheduled to begin in July 2022. CONCLUSIONS If successful, data from this study will support culturally informed treatment approaches for Black smokers and, pending findings of efficacy, provide an evidence-based mobile intervention for smoking cessation that is ready for dissemination and implementation. CLINICALTRIAL ClinicalTrials.gov NCT04838236; https://clinicaltrials.gov/ct2/show/NCT04838236 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/38905Keywords
All Related Versions
- Published version: JMIR Research Protocols, 11 (5), e38905.
This publication has 118 references indexed in Scilit:
- Prospective evaluation of the effects of anxiety sensitivity and state anxiety in predicting acute nicotine withdrawal symptoms during smoking cessation.Psychology of Addictive Behaviors, 2012
- Event-level associations between affect, alcohol intoxication, and acute dependence symptoms: Effects of urgency, self-control, and drinking experienceAddictive Behaviors, 2010
- An Internet-based abstinence reinforcement smoking cessation intervention in rural smokersDrug and Alcohol Dependence, 2009
- Contingency management and motivational enhancement: A randomized clinical trial for college student smokersNicotine & Tobacco Research, 2009
- Validation of a brief measure of anxiety-related severity and impairment: The Overall Anxiety Severity and Impairment Scale (OASIS)Journal of Affective Disorders, 2009
- Discrimination and racial disparities in health: evidence and needed researchJournal of Behavioral Medicine, 2008
- An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: Theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacyJournal of Anxiety Disorders, 2008
- Age and racial differences in the presentation and treatment of Generalized Anxiety Disorder in primary careJournal of Anxiety Disorders, 2008
- Understanding social disparities in hypertension prevalence, awareness, treatment, and control: The role of neighborhood contextSocial Science & Medicine, 2007
- Grading the severity of chronic painPain, 1992